<p>儘管宏觀問題是一個因素，但導致頂級公司股票成為藍籌股待售的更重要原因是公司特定問題。</p>
<p>一些公司特定問題可能超出管理層的控制。然而，許多此類問題源於公司高管的糟糕決策。例如，管理團隊可能過分關注最終未能實現的新項目或業務線。即使這些項目最終實現，對公司的底線影響微乎其微。</p>
<p>有時，管理團隊優先考慮財務工程而非提供最佳產品和服務可能導致不利局面。在這些情況下，公司聲譽受損導致財務表現惡化。這反過來影響了市場對股票的看法。</p>
<p>這些以及其他管理失誤，都影響以下七隻藍籌股的表現。隨着它們因底層決策而從巔峯跌落，最好遠離。</p>
<h2>蘋果（AAPL）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：sylv1rob1 / Shutterstock.com</p>
<p><strong>蘋果</strong>（NASDAQ：<strong>AAPL</strong>）股價最近有所反彈，這得益於 Mag 7 部件最新更新有關利用生成式人工智能增長趨勢的計劃。然而，今年早些時候影響 AAPL 股價表現的關鍵問題仍未消失。</p>
<p>正如瑞銀（UBS）的大衞·福特最近在一份關於 AAPL 股票的研究報告中所指出的，該公司在中國的 iPhone 需求疲軟問題尚未解決。是的，在中國，需求疲軟可能歸咎於管理層有些牽強。</p>
<p>畢竟，蘋果在中國失去市場份額並不僅僅是因為當地競爭的影響。不斷升級的地緣政治緊張局勢無疑也是一個因素。也就是説，除非蘋果要麼增加中國的需求，要麼找到其他能抵消這一阻力的方法，最好還是避開 AAPL。</p>
<h2>波音（BA）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：vaalaa / Shutterstock</p>
<p>在由於管理失誤而成為藍籌股待售的股票中，<strong>波音</strong>（NYSE：<strong>BA</strong>）絕對屬於其中。這家航空巨頭的股票經歷了重大動盪。正如你可能知道的那樣，這是由於人們對該公司商用飛機安全性的擔憂重新加劇。</p>
<p>波音的管理團隊可能有一項計劃來緩解這些擔憂，但直到公司重建聲譽的道路可能還很漫長。目前，公眾和市場將繼續以最負面的態度看待波音。</p>
<p>也就是説，作為一家將股票回購和其他類型的財務工程置於研發和航空工程之上的公司。這種策略在短期內可能會取得成功，但波音似乎正在為長遠付出代價。儘管這些問題已經導致 BA 股價自一月以來下跌三分之一，但還是要遠離。塵埃尚未落定。</p>
<h2>高樂氏（CLX）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：TY Lim / Shutterstock.com</p>
<p><strong>高樂氏</strong>（NYSE：<strong>CLX</strong>）是一家藍籌股和股息貴族，連續 46 年增加股息。四年後，如果這家家庭產品製造商繼續增加年度股息支付，該股將成為股息王。</p>
<p>然而，儘管 CLX 股票通過其 3.72% 的股息提供穩定收益，但近年來，這一收益被股價表現不佳所抵消。誠然，該公司的股價急劇下跌的很大一部分是由於疫情後的後遺症。其清潔產品的銷售在 COVID 期間激增，但自那時起銷售額和盈利能力有所下降。</p>
<p>然而，有一個糟糕的管理決定可以説已經導致股票的總回報乏善可陳。那就是不足的運營安全流程，使其容易受到去年八月的網絡攻擊。這次網絡攻擊的損失仍在影響高樂氏的財務表現。出售或避開 CLX。</p>
<h2>福特（F）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：D K Grove / Shutterstock</p>
<p>與底特律三巨頭相比，<strong>福特</strong>（NYSE：<strong>F</strong>）在轉向生產更多電動汽車（EVs）方面更為積極。市場可能在幾年前電動汽車熱潮的高峰期讚揚這種轉變。然而，現在明顯看來，福特在電動汽車領域進展過快過大。</p>
<p>事後看來，這家汽車製造商應該追求一種不同的電動汽車戰略。也許更類似於競爭對手 <strong>斯泰利斯</strong>（NYSE：<strong>STLA</strong>）的戰略。福特的電動汽車轉型使其在市場份額方面僅次於 <strong>特斯拉</strong>（NASDAQ：<strong>TSLA</strong>），但福特的電動汽車部門目前也在虧損數十億。</p>
<p>以利潤為重心的斯泰利斯，市場份額較低，但其電動汽車部門是盈利的。雖然福特正在削減其電動汽車努力，直到這一部門的現金流耗盡不再影響整體盈利能力，但考慮 F 股票為一隻藍籌股待售。</p>
<h2>IBM（IBM）</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：shutterstock.com/LCV</p>
<p>今年早些時候，市場對 <strong>IBM</strong>（NYSE：<strong>IBM</strong>）的人工智能戰略幾乎沒有什麼怨言。事實上，投資者將股價推高到近十年前的水平，因為這家擁有百年曆史的科技公司將從通用人工智能革命中獲益。</p>
<p>然而，最近，市場參與者對 IBM 股票有所猶豫。是的，其中一些可以歸因於人工智能狂熱自春季以來已經減退。然而，投資者對最新業績和指引的更新也感到失望。</p>
<p>這還不是全部。正如 Seeking Alpha 的撰稿人 Stone Fox Capital 最近所指出的，IBM 削減資本支出的事實引發了關於該公司是否真正準備好利用人工智能增長趨勢的疑問。在管理行動和業績表明出真正的人工智能增長動力之前，最好避開 IBM。</p>
<h2>耐克（Nike）(NKE)</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：Shutterstock</p>
<p>你可能認為 <strong>耐克</strong>（NYSE:<strong>NKE</strong>）是應該出售的藍籌股之一，因為這家服裝和鞋類行業領導者面臨宏觀風險。然而，高通脹和全球經濟放緩的影響並不是導致耐克最近低迷的唯一因素。</p>
<p>至少，這是 InvestorPlace 的 Marc Guberti 的觀點。本月早些時候，在闡述 NKE 股票的空頭案例時，Guberti 指出了另一個因素，這個因素完全在管理層的控制範圍內：產品創新。在這些逆風消散之前，公司可能會繼續實現令人失望的營收和盈利增長。</p>
<p>過去的失望已經將 NKE 股價拉回接近 52 周低點。然而，如果即將到來的巴黎奧運會不能成為管理層所吹捧的扭轉局面的催化劑，股價可能會進一步下跌。在考慮耐克股票時，最好不要購買。</p>
<h2>輝瑞（Pfizer）(PFE)</h2>
<p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>來源：Manuel Esteban / Shutterstock.com</p>
<p>自 2023 年以來，<strong>輝瑞</strong>（NYSE:<strong>PFE</strong>）一直是一隻價值陷阱股。換句話説，這是一隻看似被低估的股票，由於基本面糟糕而不斷走低。抄底投資者已經多次買入這隻大型製藥股，希望他們是在低點買入。</p>
<p>不幸的是，PFE 股票繼續走低。隨着輝瑞新藥銷售尚未超過下降的 COVID-19 疫苗和治療銷售的影響，該公司仍在努力。是的，輝瑞正在努力彌補過去管理失誤。一個主要例子是醫療保健分析師 Andrew Baum 加入公司擔任戰略和創新負責人。</p>
<p>然而，由於輝瑞繼續在為快速增長市場如抗肥胖開發藥物產品方面掙扎，扭轉局面可能仍需要多年時間。目前，PFE 的股價表現不佳可能會抵消股息率為 5.96% 的股票上漲的潛力。</p>
<p><em>在本文發佈之日，Thomas Niel 沒有持有（直接或間接）本文提到的任何證券頭寸。本文中表達的觀點屬於作者本人，遵守 InvestorPlace.com 的發佈準則。</em></p>
<p>自 2016 年以來，InvestorPlace.com 的撰稿人 Thomas Niel 一直為網絡出版物撰寫單支股票分析。</p>
<p>藍籌股</p>

波音

高樂氏

愛普股份

蘋果

福特汽車

3 倍做多航空航太與國防 ETF - Direxion

<p>一些頂尖公司正在做出糟糕的管理決策，導致這七隻藍籌股股價下跌。蘋果在中國面臨弱勢 iPhone 需求，而波音由於安全問題而聲譽受損。高樂氏的股價表現不佳，且容易受到網絡攻擊，因此被認為是賣出對象，而福特向電動車轉型的激進舉措事與願違。這些管理失誤正在影響這些股票的財務表現</p>

<p>While macro-related issues are a factor, it’s company-specific issues that play a more significant role in causing shares from top companies to become blue-chip stocks to sell.</p>
<div class="lb-trans"><p>儘管宏觀問題是一個因素，但導致頂級公司股票成為藍籌股待售的更重要原因是公司特定問題。</p>
</div><p>Some company-specific issues can be out of management’s control. However, many of these types of issues stem from poor decisions by a company’s C-suite. For instance, management teams can focus too much on new projects or business lines that ultimately fail to come to fruition. If they do come to fruition, they have little impact on the bottom line.</p>
<div class="lb-trans"><p>一些公司特定問題可能超出管理層的控制。然而，許多此類問題源於公司高管的糟糕決策。例如，管理團隊可能過分關注最終未能實現的新項目或業務線。即使這些項目最終實現，對公司的底線影響微乎其微。</p>
</div><p>Other times, management teams prioritizing financial engineering over providing the best products and services can end up in a bad situation. In these situations, a damaged reputation for the company leads to deteriorating financial performance. In turn, this affects the stock’s reputation in the eyes of the market.</p>
<div class="lb-trans"><p>有時，管理團隊優先考慮財務工程而非提供最佳產品和服務可能導致不利局面。在這些情況下，公司聲譽受損導致財務表現惡化。這反過來影響了市場對股票的看法。</p>
</div><p>These, and other management blunders, are in play with the following seven blue-chip stocks to sell. As they fall from the top of the heap due to bottom-shelf decisions, stay away.</p>
<div class="lb-trans"><p>這些以及其他管理失誤，都影響以下七隻藍籌股的表現。隨着它們因底層決策而從巔峯跌落，最好遠離。</p>
</div><h2>Apple (AAPL)</h2>
<div class="lb-trans"><h2>蘋果（AAPL）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: sylv1rob1 / Shutterstock.com</p>
<div class="lb-trans"><p>來源：sylv1rob1 / Shutterstock.com</p>
</div><p><strong>Apple</strong> (NASDAQ:<strong>AAPL</strong>) shares have been bouncing back lately, following the Mag 7 component’s latest updates regarding its plans to capitalize on the generative AI growth trend. However, the key issue affecting AAPL’s price performance earlier this year hasn’t gone away.</p>
<div class="lb-trans"><p><strong>蘋果</strong>（NASDAQ：<strong>AAPL</strong>）股價最近有所反彈，這得益於 Mag 7 部件最新更新有關利用生成式人工智能增長趨勢的計劃。然而，今年早些時候影響 AAPL 股價表現的關鍵問題仍未消失。</p>
</div><p>As <strong>UBS’s</strong> David Vogt recently argued, in a research note on AAPL stock, the company is “not out of the woods yet” when it comes to weak iPhone demand in China. Yes, it may be somewhat of a stretch to say that demand weakness, at least in China, is the fault of management.</p>
<div class="lb-trans"><p>正如瑞銀（UBS）的大衞·福特最近在一份關於 AAPL 股票的研究報告中所指出的，該公司在中國的 iPhone 需求疲軟問題尚未解決。是的，在中國，需求疲軟可能歸咎於管理層有些牽強。</p>
</div><p>After all, it’s not just a matter of Apple losing ground in China due to the impact of local competition. Rising geopolitical tensions are undoubtedly a factor as well. That said, until Apple either shores up Chinese demand or figures out something else that can outweigh this headwind, it may be best to avoid AAPL.</p>
<div class="lb-trans"><p>畢竟，蘋果在中國失去市場份額並不僅僅是因為當地競爭的影響。不斷升級的地緣政治緊張局勢無疑也是一個因素。也就是説，除非蘋果要麼增加中國的需求，要麼找到其他能抵消這一阻力的方法，最好還是避開 AAPL。</p>
</div><h2>Boeing (BA)</h2>
<div class="lb-trans"><h2>波音（BA）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: vaalaa / Shutterstock</p>
<div class="lb-trans"><p>來源：vaalaa / Shutterstock</p>
</div><p>When it comes to blue-chip stocks to sell due to management blunders, <strong>Boeing</strong> (NYSE:<strong>BA</strong>) definitely belongs on that list. Shares in the aerospace giant have experienced major turbulence. As you likely know, that is due to renewed concerns about the safety of the company’s commercial aircraft.</p>
<div class="lb-trans"><p>在由於管理失誤而成為藍籌股待售的股票中，<strong>波音</strong>（NYSE：<strong>BA</strong>）絕對屬於其中。這家航空巨頭的股票經歷了重大動盪。正如你可能知道的那樣，這是由於人們對該公司商用飛機安全性的擔憂重新加劇。</p>
</div><p>Boeing’s management may have a game plan to assuage these concerns, but it’s arguably a long road ahead until the company rebuilds its reputation. For now, the public and the market will continue to perceive Boeing in the most negative light.</p>
<div class="lb-trans"><p>波音的管理團隊可能有一項計劃來緩解這些擔憂，但直到公司重建聲譽的道路可能還很漫長。目前，公眾和市場將繼續以最負面的態度看待波音。</p>
</div><p>That is, as a company that prioritized stock buybacks and other types of financial engineering over R&amp;D and aerospace engineering. That strategy may have paid off in the near term, but Boing is seemingly paying the price in the long run. While these issues have already knocked BA stock down by a third since January, stay away. The dust has yet to settle.</p>
<div class="lb-trans"><p>也就是説，作為一家將股票回購和其他類型的財務工程置於研發和航空工程之上的公司。這種策略在短期內可能會取得成功，但波音似乎正在為長遠付出代價。儘管這些問題已經導致 BA 股價自一月以來下跌三分之一，但還是要遠離。塵埃尚未落定。</p>
</div><h2>Clorox (CLX)</h2>
<div class="lb-trans"><h2>高樂氏（CLX）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: TY Lim / Shutterstock.com</p>
<div class="lb-trans"><p>來源：TY Lim / Shutterstock.com</p>
</div><p><strong>Clorox</strong> (NYSE:<strong>CLX</strong>) is a blue-chip stock and a Dividend Aristocrat, with 46 years of consecutive dividend growth. Four years from now, if the household products manufacturer continues to increase its annual dividend payouts, the stock will become a Dividend King.</p>
<div class="lb-trans"><p><strong>高樂氏</strong>（NYSE：<strong>CLX</strong>）是一家藍籌股和股息貴族，連續 46 年增加股息。四年後，如果這家家庭產品製造商繼續增加年度股息支付，該股將成為股息王。</p>
</div><p>Yet, while CLX stock provides steady gains from its 3.72% dividend, in recent years that has been outweighed by the stock’s poor price performance. Admittedly, much of the stock’s steep declines have been due to the company’s post-pandemic hangover. Sales of its cleaning products surged during COVID, but sales and profitability have declined since.</p>
<div class="lb-trans"><p>然而，儘管 CLX 股票通過其 3.72% 的股息提供穩定收益，但近年來，這一收益被股價表現不佳所抵消。誠然，該公司的股價急劇下跌的很大一部分是由於疫情後的後遺症。其清潔產品的銷售在 COVID 期間激增，但自那時起銷售額和盈利能力有所下降。</p>
</div><p>However, there is one bad management decision that arguably has contributed to lackluster total returns for shares. That would be inadequate operational security processes, which left it vulnerable to a cyberattack last August. The damage from this cyberattack is still affecting Clorox’s fiscal performance. Sell or avoid CLX.</p>
<div class="lb-trans"><p>然而，有一個糟糕的管理決定可以説已經導致股票的總回報乏善可陳。那就是不足的運營安全流程，使其容易受到去年八月的網絡攻擊。這次網絡攻擊的損失仍在影響高樂氏的財務表現。出售或避開 CLX。</p>
</div><h2>Ford (F)</h2>
<div class="lb-trans"><h2>福特（F）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: D K Grove / Shutterstock.com</p>
<div class="lb-trans"><p>來源：D K Grove / Shutterstock</p>
</div><p>Compared to its Detroit Three rivals, <strong>Ford</strong> (NYSE:<strong>F</strong>) has been far more aggressive in its pivot towards producing more electric vehicles (EVs). The market may have lauded this change in focus during the height of EV mania several years ago. However, it’s clear now that Ford went too big and too fast with vehicle electrification.</p>
<div class="lb-trans"><p>與底特律三巨頭相比，<strong>福特</strong>（NYSE：<strong>F</strong>）在轉向生產更多電動汽車（EVs）方面更為積極。市場可能在幾年前電動汽車熱潮的高峰期讚揚這種轉變。然而，現在明顯看來，福特在電動汽車領域進展過快過大。</p>
</div><p>In hindsight, the automaker should have pursued a different EV strategy. Perhaps one more akin to that of competitor <strong>Stellantis</strong> (NYSE:<strong>STLA</strong>). Ford’s EV transformation has resulted in it becoming behind only <strong>Tesla</strong> (NASDAQ:<strong>TSLA</strong>) in terms of market share, but Ford’s EV division is also currently losing billions.</p>
<div class="lb-trans"><p>事後看來，這家汽車製造商應該追求一種不同的電動汽車戰略。也許更類似於競爭對手 <strong>斯泰利斯</strong>（NYSE：<strong>STLA</strong>）的戰略。福特的電動汽車轉型使其在市場份額方面僅次於 <strong>特斯拉</strong>（NASDAQ：<strong>TSLA</strong>），但福特的電動汽車部門目前也在虧損數十億。</p>
</div><p>Margin-focused Stellantis, on the other hand, has a lower market share yet its EV division is profitable. While Ford is scaling back its EV efforts until cash burn from this segment ceases to affect overall profitability, consider F stock one of the blue-chip stocks to sell.</p>
<div class="lb-trans"><p>以利潤為重心的斯泰利斯，市場份額較低，但其電動汽車部門是盈利的。雖然福特正在削減其電動汽車努力，直到這一部門的現金流耗盡不再影響整體盈利能力，但考慮 F 股票為一隻藍籌股待售。</p>
</div><h2>IBM (IBM)</h2>
<div class="lb-trans"><h2>IBM（IBM）</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: shutterstock.com/LCV</p>
<div class="lb-trans"><p>來源：shutterstock.com/LCV</p>
</div><p>Earlier this year, the market had few complaints about <strong>IBM’s</strong> (NYSE:<strong>IBM</strong>) AI strategy. In fact, investors bid up shares to prices last hit nearly a decade ago, on the view that the more than century-old tech firm would benefit greatly from the gen AI revolution.</p>
<div class="lb-trans"><p>今年早些時候，市場對 <strong>IBM</strong>（NYSE：<strong>IBM</strong>）的人工智能戰略幾乎沒有什麼怨言。事實上，投資者將股價推高到近十年前的水平，因為這家擁有百年曆史的科技公司將從通用人工智能革命中獲益。</p>
</div><p>More recently, however, market participants have had second thoughts about IBM stock. Yes, some of this can be chalked up to the fact that AI mania has waned since the spring. However, investors were also disappointed with the latest results and updates to guidance.</p>
<div class="lb-trans"><p>然而，最近，市場參與者對 IBM 股票有所猶豫。是的，其中一些可以歸因於人工智能狂熱自春季以來已經減退。然而，投資者對最新業績和指引的更新也感到失望。</p>
</div><p>That’s not all. As Seeking Alpha contributor Stone Fox Capital recently argued, the fact that IBM is cutting back on capital expenditures raises questions over whether the company is really poised to capitalize on the AI growth trend. Until management actions and results indicate a bona fide AI growth catalyst, consider it best to steer clear of Big Blue.</p>
<div class="lb-trans"><p>這還不是全部。正如 Seeking Alpha 的撰稿人 Stone Fox Capital 最近所指出的，IBM 削減資本支出的事實引發了關於該公司是否真正準備好利用人工智能增長趨勢的疑問。在管理行動和業績表明出真正的人工智能增長動力之前，最好避開 IBM。</p>
</div><h2>Nike (NKE)</h2>
<div class="lb-trans"><h2>耐克（Nike）(NKE)</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: Shutterstock</p>
<div class="lb-trans"><p>來源：Shutterstock</p>
</div><p>You may think <strong>Nike</strong> (NYSE:<strong>NKE</strong>) is one of the blue-chip stocks to sell due to macro headwinds for this leader in the apparel and footwear industry. However, the impact of high inflation and a global economic slowdown aren’t the only factors driving Nike’s recent slump.</p>
<div class="lb-trans"><p>你可能認為 <strong>耐克</strong>（NYSE:<strong>NKE</strong>）是應該出售的藍籌股之一，因為這家服裝和鞋類行業領導者面臨宏觀風險。然而，高通脹和全球經濟放緩的影響並不是導致耐克最近低迷的唯一因素。</p>
</div><p>At least, that’s the view of InvestorPlace’s Marc Guberti. Earlier this month, when laying out the NKE stock bear case, Guberti pointed to another factor, one that’s well within management’s control: product innovation. Until these headwinds dissipate, the company will likely continue to deliver underwhelming revenue and earnings growth.</p>
<div class="lb-trans"><p>至少，這是 InvestorPlace 的 Marc Guberti 的觀點。本月早些時候，在闡述 NKE 股票的空頭案例時，Guberti 指出了另一個因素，這個因素完全在管理層的控制範圍內：產品創新。在這些逆風消散之前，公司可能會繼續實現令人失望的營收和盈利增長。</p>
</div><p>Past disappointment has already knocked NKE back down near its 52-week low. However, if the upcoming Paris Olympics fail to be the turnaround catalyst that management has hyped it up to be, further price declines could be in the cards. When it comes to Nike stock, just don’t buy it.</p>
<div class="lb-trans"><p>過去的失望已經將 NKE 股價拉回接近 52 周低點。然而，如果即將到來的巴黎奧運會不能成為管理層所吹捧的扭轉局面的催化劑，股價可能會進一步下跌。在考慮耐克股票時，最好不要購買。</p>
</div><h2>Pfizer (PFE)</h2>
<div class="lb-trans"><h2>輝瑞（Pfizer）(PFE)</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif" alt="" original-src="https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif"/></p>
<p>Source: Manuel Esteban / Shutterstock.com</p>
<div class="lb-trans"><p>來源：Manuel Esteban / Shutterstock.com</p>
</div><p>Since 2023, <strong>Pfizer</strong> (NYSE:<strong>PFE</strong>) has been a value trap stock. In other words, a seemingly undervalued stock that due to poor fundamentals keeps on getting cheaper. Bottom-fishing investors have bought the dip many times with the big pharma stock, hoping they were buying in at the bottom.</p>
<div class="lb-trans"><p>自 2023 年以來，<strong>輝瑞</strong>（NYSE:<strong>PFE</strong>）一直是一隻價值陷阱股。換句話説，這是一隻看似被低估的股票，由於基本面糟糕而不斷走低。抄底投資者已經多次買入這隻大型製藥股，希望他們是在低點買入。</p>
</div><p>Unfortunately, PFE stock has continued to trend lower. The impact of declining COVID-19 vaccine and treatment sales has yet to be outweighed by the sale of new drugs in Pfizer’s pipeline. Yes, Pfizer is trying to make up for past management missteps. A prime example is the onboarding of healthcare analyst Andrew Baum as the company’s new head of strategy and innovation.</p>
<div class="lb-trans"><p>不幸的是，PFE 股票繼續走低。隨着輝瑞新藥銷售尚未超過下降的 COVID-19 疫苗和治療銷售的影響，該公司仍在努力。是的，輝瑞正在努力彌補過去管理失誤。一個主要例子是醫療保健分析師 Andrew Baum 加入公司擔任戰略和創新負責人。</p>
</div><p>However, as Pfizer continues to struggle to develop drug products for fast-growing markets like anti-obesity, a turnaround may still be many years in the making. For now, PFE’s poor price performance could keep countering the upside from the stock’s 5.96% dividend.</p>
<div class="lb-trans"><p>然而，由於輝瑞繼續在為快速增長市場如抗肥胖開發藥物產品方面掙扎，扭轉局面可能仍需要多年時間。目前，PFE 的股價表現不佳可能會抵消股息率為 5.96% 的股票上漲的潛力。</p>
</div><p><em>On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com</em> <em>Publishing Guidelines</em>.</p>
<div class="lb-trans"><p><em>在本文發佈之日，Thomas Niel 沒有持有（直接或間接）本文提到的任何證券頭寸。本文中表達的觀點屬於作者本人，遵守 InvestorPlace.com 的發佈準則。</em></p>
</div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p>
<div class="lb-trans"><p>自 2016 年以來，InvestorPlace.com 的撰稿人 Thomas Niel 一直為網絡出版物撰寫單支股票分析。</p>
</div><p>Blue-Chip Stocks</p>
<div class="lb-trans"><p>藍籌股</p>
</div>

藍籌股失誤：管理層失誤不斷增加的 7 只股票